These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 29042774)
1. Reductive nanocomplex encapsulation of cRGD-siRNA conjugates for enhanced targeting to cancer cells. Zhou Z; Liu S; Zhang Y; Yang X; Ma Y; Guan Z; Wu Y; Zhang L; Yang Z Int J Nanomedicine; 2017; 12():7255-7272. PubMed ID: 29042774 [TBL] [Abstract][Full Text] [Related]
2. Construction of a Targeting Nanoparticle of 3',3″-Bis-Peptide-siRNA Conjugate/Mixed Lipid with Postinserted DSPE-PEG2000-cRGD. Zhang Y; Li S; Zhou X; Sun J; Fan X; Guan Z; Zhang L; Yang Z Mol Pharm; 2019 Dec; 16(12):4920-4928. PubMed ID: 31642677 [TBL] [Abstract][Full Text] [Related]
3. cRGD peptide-conjugated polyethylenimine-based lipid nanoparticle for intracellular delivery of siRNA in hepatocarcinoma therapy. Yang S; Wang D; Zhang X; Sun Y; Zheng B Drug Deliv; 2021 Dec; 28(1):995-1006. PubMed ID: 34042551 [TBL] [Abstract][Full Text] [Related]
4. A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells. Li G; Hu Z; Yin H; Zhang Y; Huang X; Wang S; Li W Int J Nanomedicine; 2013; 8():1293-306. PubMed ID: 23569377 [TBL] [Abstract][Full Text] [Related]
5. Feasibility of cRGD conjugation at 5'-antisense strand of siRNA by phosphodiester linkage extension. Zhou X; Pan Y; Yu L; Wu J; Li Z; Li H; Guan Z; Tang X; Yang Z Mol Ther Nucleic Acids; 2021 Sep; 25():603-612. PubMed ID: 34589281 [TBL] [Abstract][Full Text] [Related]
6. Coated microneedles mediated intradermal delivery of octaarginine/BRAF siRNA nanocomplexes for anti-melanoma treatment. Ruan W; Zhai Y; Yu K; Wu C; Xu Y Int J Pharm; 2018 Dec; 553(1-2):298-309. PubMed ID: 30347273 [TBL] [Abstract][Full Text] [Related]
7. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles. Yi Y; Kim HJ; Mi P; Zheng M; Takemoto H; Toh K; Kim BS; Hayashi K; Naito M; Matsumoto Y; Miyata K; Kataoka K J Control Release; 2016 Dec; 244(Pt B):247-256. PubMed ID: 27590214 [TBL] [Abstract][Full Text] [Related]
8. RGD-decorated cholesterol stabilized polyplexes for targeted siRNA delivery to glioblastoma cells. Lou B; Connor K; Sweeney K; Miller IS; O'Farrell A; Ruiz-Hernandez E; Murray DM; Duffy GP; Wolfe A; Mastrobattista E; Byrne AT; Hennink WE Drug Deliv Transl Res; 2019 Jun; 9(3):679-693. PubMed ID: 30972664 [TBL] [Abstract][Full Text] [Related]
9. Biological Properties of a 3',3″-Bis-Peptide-siRNA Conjugate in Vitro and in Vivo. Fan X; Zhang Y; Liu X; He H; Ma Y; Sun J; Huang Y; Wang X; Wu Y; Zhang L; Yang Z Bioconjug Chem; 2016 Apr; 27(4):1131-42. PubMed ID: 26963141 [TBL] [Abstract][Full Text] [Related]
10. cRGD grafted liposomes containing inorganic nano-precipitate complexed siRNA for intracellular delivery in cancer cells. Khatri N; Baradia D; Vhora I; Rathi M; Misra A J Control Release; 2014 May; 182():45-57. PubMed ID: 24631861 [TBL] [Abstract][Full Text] [Related]
11. SiRNA-phospholipid conjugates for gene and drug delivery in cancer treatment. Liu H; Li Y; Mozhi A; Zhang L; Liu Y; Xu X; Xing J; Liang X; Ma G; Yang J; Zhang X Biomaterials; 2014 Aug; 35(24):6519-33. PubMed ID: 24797882 [TBL] [Abstract][Full Text] [Related]
12. Multivalent cyclic RGD conjugates for targeted delivery of small interfering RNA. Alam MR; Ming X; Fisher M; Lackey JG; Rajeev KG; Manoharan M; Juliano RL Bioconjug Chem; 2011 Aug; 22(8):1673-81. PubMed ID: 21755983 [TBL] [Abstract][Full Text] [Related]
13. Tetrahedral Framework Nucleic Acids Loaded with Aptamer AS1411 for siRNA Delivery and Gene Silencing in Malignant Melanoma. Xiao D; Li Y; Tian T; Zhang T; Shi S; Lu B; Gao Y; Qin X; Zhang M; Wei W; Lin Y ACS Appl Mater Interfaces; 2021 Feb; 13(5):6109-6118. PubMed ID: 33497198 [TBL] [Abstract][Full Text] [Related]
14. The role of disulfide-bridge on the activities of H-shape gemini-like cationic lipid based siRNA delivery. Ma XF; Sun J; Qiu C; Wu YF; Zheng Y; Yu MZ; Pei XW; Wei L; Niu YJ; Pang WH; Yang ZJ; Wang JC; Zhang Q J Control Release; 2016 Aug; 235():99-111. PubMed ID: 27242198 [TBL] [Abstract][Full Text] [Related]
15. A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo. He S; Cen B; Liao L; Wang Z; Qin Y; Wu Z; Liao W; Zhang Z; Ji A Drug Deliv; 2017 Nov; 24(1):471-481. PubMed ID: 28181832 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and Evaluation of Caged siRNAs with Single cRGD Modification for Photoregulating RNA Interference. Yu L; Liang D; Jing N; Chen C; Tang X Methods Mol Biol; 2020; 2115():133-161. PubMed ID: 32006399 [TBL] [Abstract][Full Text] [Related]
17. Caged siRNAs with Single cRGD Modification for Photoregulation of Exogenous and Endogenous Gene Expression in Cells and Mice. Yu L; Liang D; Chen C; Tang X Biomacromolecules; 2018 Jul; 19(7):2526-2534. PubMed ID: 29727579 [TBL] [Abstract][Full Text] [Related]
18. Structure Tuning of Cationic Oligospermine-siRNA Conjugates for Carrier-Free Gene Silencing. Nothisen M; Bagilet J; Behr JP; Remy JS; Kotera M Mol Pharm; 2016 Aug; 13(8):2718-28. PubMed ID: 27398779 [TBL] [Abstract][Full Text] [Related]
19. Tumor-targeted in vivo gene silencing via systemic delivery of cRGD-conjugated siRNA. Liu X; Wang W; Samarsky D; Liu L; Xu Q; Zhang W; Zhu G; Wu P; Zuo X; Deng H; Zhang J; Wu Z; Chen X; Zhao L; Qiu Z; Zhang Z; Zeng Q; Yang W; Zhang B; Ji A Nucleic Acids Res; 2014 Oct; 42(18):11805-17. PubMed ID: 25223783 [TBL] [Abstract][Full Text] [Related]
20. Multilayered polyion complexes with dissolvable silica layer covered by controlling densities of cRGD-conjugated PEG chains for cancer-targeted siRNA delivery. Naito M; Azuma R; Takemoto H; Hori M; Yoshinaga N; Osawa S; Kamegawa R; Kim HJ; Ishii T; Nishiyama N; Miyata K; Kataoka K J Biomater Sci Polym Ed; 2017; 28(10-12):1109-1123. PubMed ID: 28278046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]